News
TScan Therapeutics, Inc.’s TCRX share price has surged by 9.62%, which has investors questioning if this is right time to sell.
Coherus BioSciences, Inc.’s CHRS share price has dipped by 5.19%, which has investors questioning if this is right time to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results